arrow
G

Gianni Sorarú

department of neurosciences
H指数:51
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

RYR1-Related Myopathies Involve More than Calcium Dysregulation: Insights from Transcriptomic Profiling

RYR1相关肌病涉及更多于钙离子稳态失调:转录组分析提供的见解

2025-11-150
OAAI
Cortical Excitability as a Prognostic and Phenotypic Stratification Biomarker in Amyotrophic Lateral Sclerosis

皮质兴奋性作为肌萎缩侧索硬化症的预后和表型分层生物标志物

2025-06-250
OAAI
MEPs and MRI Motor Band Sign as Potential Complementary Markers of Upper Motor Neuron Involvement in Amyotrophic Lateral Sclerosis

欧洲议会议员和MRI运动带信号作为肌萎缩侧索硬化症中上运动神经元受累的潜在互补性标志物

2025-02-060
OAAI
Blood biomarkers for Alzheimer's disease with the Lumipulse automated platform: Age-effect and clinical value interpretation

使用Lumipulse自动化平台的阿尔茨海默病血液生物标志物: 年龄效应和临床价值解释

2025-01-010
OAAI
Protective role of Angiogenin in muscle regeneration in amyotrophic lateral sclerosis: Diagnostic and therapeutic implications

血管生成素在肌萎缩侧索硬化肌肉再生中的保护作用: 诊断和治疗意义

2024-12-280
OAAI
Changes in Cerebrospinal Fluid Concentrations of Selenium Species Induced by Tofersen Administration in Subjects with Amyotrophic Lateral Sclerosis Carrying SOD1 Gene Mutations

携带SOD1基因突变的肌萎缩侧索硬化症患者Tofersen给药诱导的硒类脑脊液浓度变化

2024-07-175
OAAI
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis
2023-08-1723
OAAI
Immune-mediated myogenesis and acetylcholine receptor clustering promote a slow disease progression in ALS mouse models (vol 43, 19, 2023)
2023-04-192
OAAI
Immune-mediated myogenesis and acetylcholine receptor clustering promote a slow disease progression in ALS mouse models
2023-03-0910
OAAI
LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice
2023-02-0613
OAAI